Labshake search
Citations for R&D Systems :
1 - 50 of 222 citations for GM CSF Rhesus Macaque since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2020Quote: ... 10ng/mL GM-CSF (R&D Systems, 215-GM) with 250nM dasatinib (Selleck Chemicals ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL GM-CSF (R&D Systems 215-GM), and 3 U/mL EPO (R&D Systems 287-TC) ...
-
bioRxiv - Biochemistry 2021Quote: ... and 50 ng/mL GM-CSF (215-GM, R&D systems) and seeded in 96-well plates (105/well ...
-
bioRxiv - Immunology 2020Quote: ... and 50 ng/mL GM-CSF (215-GM; R&D Systems). KhES1 ESCs were kindly provided by Dr ...
-
bioRxiv - Cell Biology 2020Quote: ... GM-CSF (R&D systems, Minneapolis, MN), and MIP1α (R&D systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... 100 ng/mL GM-CSF (R&D Systems) and 10 ng/mL IL-4 (R&D Systems) ...
-
bioRxiv - Immunology 2021Quote: ... and 20ng/ml GM-CSF (R&D System) at 37°C ...
-
bioRxiv - Immunology 2023Quote: ... GM-CSF (100 U/µl, R&D systems), BAY11-7082 (2.5 µM ...
-
bioRxiv - Immunology 2023Quote: ... GM-CSF (1000 U/µl, R&D Systems), Staphylococcus-Enterotoxin-B (SEB ...
-
Immunoresolvents Support Skeletal Myofiber Regeneration via Actions on Myeloid and Muscle Stem CellsbioRxiv - Immunology 2020Quote: ... and human recombinant GM-CSF (20 ng/mL) (R&D Systems, 215-GM-010). Cells then were washed with PBS to remove non-adherent cells and detached by incubation in TrypLE Select at 37°C followed by gentle cell scraping ...
-
bioRxiv - Cancer Biology 2022Quote: ... Human GM-CSF biotinylated antibody (R&D Systems, BAM215) was added to the medium to a final concentration of 90 ng/ml and incubated at room temperature with gentle shaking for 3 hours ...
-
bioRxiv - Immunology 2019Quote: ... and GM-CSF (50 ng/ml, R&D Systems) for seven days ...
-
bioRxiv - Immunology 2020Quote: ... and 800 U/mL GM-CSF (R&D Systems) for 6 days ...
-
bioRxiv - Immunology 2021Quote: ... and GM-CSF (50 ng/mL, R&D Systems). For macrophage differentiation ...
-
bioRxiv - Neuroscience 2023Quote: ... mouse GM-CSF (R&D Systems, 415- ML-010) or vehicle (PBS with Ca2+ and Mg2+ ...
-
bioRxiv - Neuroscience 2024Quote: ... and 10 ng/ml GM-CSF (R&D System)] and plated onto 12 mm glass coverslips ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with 20 ng/ml of recombinant murine GM-CSF (rmGM-CSF, R&D systems). Plates were incubated in humidified atmosphere at 37°C ...
-
bioRxiv - Microbiology 2020Quote: ... GM-CSF and IL-3 [all from R&D Systems]) ...
-
bioRxiv - Immunology 2021Quote: ... GM-CSF and CCL5 from R&D Systems (Minneapolis, USA), IFNγ from Biolegend (San Diego ...
-
bioRxiv - Immunology 2020Quote: ... and 20 ng GM-CSF (R&D systems, Minneapolis, MN) per ml medium ...
-
bioRxiv - Immunology 2023Quote: ... and 50 ng/ml of GM-CSF (R&D Systems) (G4 Media ...
-
bioRxiv - Immunology 2023Quote: ... supernatants were collected and concentrations of IFN-γ and GM-CSF were determined using ELISA kits from R&D Systems (IFN-γ; DIF50C, GM-CSF; DGM00) according to the manufacturer’s instructions.
-
bioRxiv - Neuroscience 2021Quote: ... and treated with GM-CSF (2.5 ng/mL; R&D Systems) to enhance microglial proliferation ...
-
bioRxiv - Neuroscience 2022Quote: ... recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems), and recombinant IL-34 (IL-34 ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 50 ng/mL human GM-CSF (R&D Systems) to stimulate macrophage differentiation ...
-
bioRxiv - Immunology 2020Quote: ... and cultured for 6 days with recombinant GM-CSF (R&D Systems cat. 215-GM, 50 ng/ml) and IL-4 (R&D Systems cat ...
-
bioRxiv - Molecular Biology 2022Quote: ... human recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF, 50 ng/mL R&D Systems, 7954-GM-020/CF), and interleukin-4 (IL-4 ...
-
bioRxiv - Immunology 2021Quote: GM-CSF (Granulocyte Macrophage Colony Stimulating Factor) (R&D Systems, Minneapolis, USA), M-CSF (Macrophage Colony Stimulating Factor ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... supplemented with 50 ng/ml GM-CSF (Recombinant human, R&D Systems), 10% heat-inactivated FBS (Gibco) ...
-
bioRxiv - Genetics 2022Quote: ... Growth medium for TF-1 was also supplemented with 2ng/mL of GM-CSF (R&D systems #7954-GM-010). Mycoplasma PCR testing of these cells was performed every four weeks ...
-
Fine tuning of CpG spatial distribution with DNA origami for improved therapeutic cancer vaccinationbioRxiv - Synthetic Biology 2023Quote: ... 20 ng/mL granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D Systems) and penicillin–streptomycin ...
-
bioRxiv - Microbiology 2021Quote: ... 1 U/ml penicillin/streptomycin) with 3 ng/ml recombinant mouse GM-CSF (rGM-CSF; R&D Systems or BioLegend)) at a concentration of 2.5 x 105 cells/ml in 150 x 15 mm petri plates at 37°C with 5% CO2 ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems, Minneapolis, MN), recombinant human interleukin 4 (IL-4 ...
-
bioRxiv - Microbiology 2021Quote: ... gradient and treated with macrophage colony stimulator (M-CSF) or granulocyte-macrophage-stimulating factor (GM-CSF) and IL-4 (R&D system) respectively for 7 days ...
-
bioRxiv - Microbiology 2021Quote: ... and then treated with macrophage colony stimulator (M-CSF) or granulocyte-macrophage-stimulating factor (GM-CSF) and IL-4 (R&D system) for 7 days.
-
bioRxiv - Cancer Biology 2022Quote: ... or the combination of both drugs in methylcellulose media enriched with human cytokines (recombinant human SCF, GM-CSF, G-CSF, IL-3, IL-6, Epo, #HSC005, R&D Systems). The methylcellulose mixture was plated in three replicates to 35 mm culture dishes using regular syringes with 16 gauge non-stick needles and incubated at 37°C ...
-
bioRxiv - Biochemistry 2024Quote: ... Gi-bound complex sample) or mixed with 0.5 mg/mL CXCL12 (Recombinant Human/Rhesus Macaque/Feline CXCL12/SDF-1 alpha, R&D Systems Catalog #: 350-NS-050/CF), or 1 mM AMD3100 (AMD 3100 octahydrochloride ...
-
bioRxiv - Microbiology 2024Quote: ... CD14+ monocytes were stimulated in non-tissue culture treated plates with 100ng/mL GM-CSF (R&D Systems, Cat# 7954-GM-020/CF) and IL-4 (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... Cells were counted and plated in 20ng/mL GM-CSF (Peprotech or R&D Systems) and 2ng/mL TGF-β (R&D Systems) ...
-
bioRxiv - Microbiology 2023Quote: ... The cells were then incubated in the presence of 50 ng/mL of GM-CSF (02532, Stem Cells, Vancouver, Canada) and 50 ng/mL of M-CSF (216-MC, R&D Systems, Minneapolis, USA) at 37°C and 5% CO2 for differentiation ...
-
bioRxiv - Immunology 2021Quote: ... TF-I cells medium contained 2 ng/ml of recombinant human GM-CSF (R&D Systems). Cells have been cultured for no longer than 4 weeks after thawing and were regularly tested for Mycoplasma contamination using PCR technique and were confirmed to be negative.
-
bioRxiv - Neuroscience 2022Quote: ... and 0.01 μg ml −1 of granulocyte macrophage colony-stimulating factor (GM-CSF; R&D Systems). After 7 days ...
-
bioRxiv - Cancer Biology 2022Quote: ... The recombinant cytokines that were used were Recombinant Human GM-CSF Protein (R&D Systems, 215GM), Recombinant Human CCL20/MIP-3α Protein (R&D Systems ...
-
bioRxiv - Microbiology 2023Quote: ... Recombinant porcine GM-CSF protein (711-PG-010) was purchased from R&D System (Minnesota, USA). SM-164 (HY-15989) ...
-
bioRxiv - Microbiology 2024Quote: ... and differentiated into M1 or M2 macrophages by incubation for 7 days in the presence of 100 ng/mL recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) or macrophage-colony stimulating factor (M-CSF) (R&D Systems, Minneapolis, MN, USA), respectively.
-
bioRxiv - Immunology 2022Quote: ... 1% penicillin/streptomycin (Cytiva, Marlborough, MA) and 20 ng/mL GM-CSF (R&D Systems, Minneapolis, MN) (DC media ...
-
bioRxiv - Neuroscience 2022Quote: ... the medium was changed to that which contained 25 ng/ml mouse GM-CSF (R&D Systems). The primary microglia were harvested by shaking (200 rpm ...
-
bioRxiv - Neuroscience 2023Quote: ... Recombinant mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) was purchased from R&D systems (415ML/CF), recombinant human Interferon gamma1b (IFNγ1b ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (50 ng/mL) (R&D Systems) and recombinant human interleukin-4 (IL-4 ...
-
bioRxiv - Microbiology 2023Quote: ... Monocyte-derived macrophages were differentiated from primary monocytes by 50 ng/ml GM-CSF (R&D Systems) treatment for 6-10 days ...